A new nanobiotic: syntheaA new nanobiotic: synthesis and characterization of an albumin nanoparticle with intrinsic antibiotic activitysis and characterization of an albumin nanoparticle with intrinsic antibiotic activity
,
Abstract
Background and Objectives: With entering the “post-antibiotic era”, antibiotic resistance is one of the most important problems in food security, health and medicine. Invention of nanoparticles with intrinsic antimicrobial activity has been provided a new tool to combat the problem, including some metal nanoparticles. But protein nanoparticles have been often used as nano-carrier for antibiotic drugs, not for their own antibiotic activity. In this article we have fabricated a very small BSA-NP without any chemical modification on BSA molecules showing antibacterial activity.
Materials and Methods: Bovine serum albumin nanoparticle (BSA-NP) was synthesized using botton-up approach, by dissolution of BSA in urea-containing Tris buffer for 60 min at 60°C. Then, the BSA solution was dialyzed against distilled water in order to nanoparticle formation. The resulted BSA-NP has been characterized by dynamic light scattering (DLS), field emission surface electron microscopy (FESEM), SDS-PAGE, Fourier transform infrared spectroscopy (FTIR) and UV-spectrophotometery. Minimum inhibitory concentration (MIC) method was used for evaluation of antibacterial activity of BSA-NP against Staphylococcus aureus and Pseudomonas aeruginosa.
Results: The results obtained by DLS technique indicated that BSA molecules were self-assembled into small aggregates with a hydrodynamic diameter of 23.23 ± 2.1 nm. With a small polydispersity index (PDI=0.522), the nanoparticles had good spherical uniformity. The nanoparticles made from a single type of protein molecule (BSA) and have a relatively transparent appearance. The BSA-NPs caused a decrease in cell growth of both P. aeruginosa and S. aureus. Moreover, they had a bacteriostatic effect on P. aeruginosa (MIC=112×10-5 μM).
Conclusion: In this study, using a green synthesis method, we succeeded in synthesizing a very small uniform BSA nanoparticles without any chemical modification on BSA molecules. It also has bacteriostatic properties against P. aeruginosa. Therefore, it is hypothesized that our BSA-NPs may be effective as a new approach to combat antibiotic resistance.
2. Chakraborty N, Jha D, Roy I, Kumar P, Gaurav SS, Marimuthu K, et al. Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies. J Nanobiotechnology 2022; 20: 375.
3. Chen S, Chen Q, Li Q, An J, Sun P, Ma J, et al. Biodegradable synthetic antimicrobial with aggregation-induced emissive luminogens for temporal antibacterial activity and facile bacteria detection. Chem Mater 2018; 30: 1782-1790.
4. Ren S, Boo C, Guo N, Wang S, Elimelech M, Wang Y. Photocatalytic reactive ultrafiltration membrane for removal of antibiotic resistant bacteria and antibiotic resistance genes from wastewater effluent. Environ Sci Technol 2018; 52: 8666–8673.
5. Yang Y, He P, Wang Y, Bai H, Wang S, Xu JF, et al. Supramolecular radical anions triggered by bacteria in situ for selective photothermal therapy. Angew Chem Int Ed Engl 2017; 56: 16239-16242.
6. Batalha IL, Bernut A, Schiebler M, Ouberai MM, Passemar C, Klapholz C, et al. Polymeric nanobiotics as a novel treatment for mycobacterial infections. J Control Release 2019; 314: 116-124.
7. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-2110.
8. Jahanshahi M, Zhang Z, Lyddiatt A. Subtractive chromatography for purification and recovery of nano-bioproducts. IEE Proc Nanobiotechnol 2005; 152: 121-126.
9. Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int 2014; 2014: 180549.
10. Afzal O, Altamimi ASA, Nadeem MS, Alzarea SI, Almalki WH, Tariq A, et al. Nanoparticles in drug delivery: from history to therapeutic applications. Nanomaterials (Basel) 2022; 12: 4494.
11. Verma D, Gulati N, Kaul S, Mukherjee S, Nagaich U. Protein based nanostructures for drug delivery. J Pharm (Cairo) 2018; 2018: 9285854.
12. Zhang L, Yao L, Zhao F, Yu A, Zhou Y, Wen Q, et al. Protein and peptide-based nanotechnology for enhancing stability, bioactivity, and delivery of anthocyanins. Adv Healthc Mater 2023; e2300473.
13. Roufegarinejad L, Jahanban‐Esfahlan A, Sajed‐Amin S, Panahi‐Azar V, Tabibiazar M. Molecular interactions of thymol with bovine serum albumin: Spectroscopic and molecular docking studies. J Mol Recognit 2018; 31(7): e2704.
14. Jahanban‐Esfahlan A, Panahi‐Azar V, Sajedi S. Spectroscopic and molecular docking studies on the interaction between N‐acetyl cysteine and bovine serum albumin. Biopolymers 2015; 103: 638-645.
15. Patel A, Patel M, Yang X, Mitra AK. Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein Pept Lett 2014; 21: 1102-1120.
16. Jahanban-Esfahlan A, Panahi-Azar V. Interaction of glutathione with bovine serum albumin: Spectroscopy and molecular docking. Food Chem 2016; 202: 426-431.
17. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 2012; 157: 168-182.
18. Vogel SM, Minshall RD, Pilipović M, Tiruppathi C, Malik AB. Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1512-22.
19. Desai N, Trieu V, Damascelli B, Soon-Shiong P. SPARC expression correlates with tumor response to albumin-bound paclitaxel in head and neck cancer patients. Transl Oncol 2009; 2: 59-64.
20. Simões S, Slepushkin V, Pires P, Gaspar R, de Lima MCP, Düzgüneş N. Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim Biophys Acta 2000; 1463: 459-469.
21. Belinskaia DA, Voronina PA, Shmurak VI, Vovk MA, Batalova AA, Jenkins RO, et al. The universal soldier: enzymatic and non-enzymatic antioxidant functions of serum albumin. Antioxidants (Basel) 2020; 9: 966.
22. De Simone G, di Masi A, Ascenzi P. Serum albumin: a multifaced enzyme. Int J Mol Sci 2021; 22: 10086.
23. Igathinathane C, Pordesimo LO, Columbus EP, Batchelor WD, Methuku SR. Shape identification and particles size distribution from basic shape parameters using ImageJ. Comput Electron Agric 2008; 63: 168-182.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
25. Thalhammer-Thurner GC, Debbage P. Albumin-based nanoparticles: small, uniform and reproducible.
Nanoscale Adv 2023; 5: 503-512.
26. Bocedi A, Cattani G, Stella L, Massoud R, Ricci G. Thiol disulfide exchange reactions in human serum albumin: the apparent paradox of the redox transitions of Cys34. FEBS J 2018; 285: 3225-3237.
27. Molina AM, Morales-Cruz M, Benítez M, Berríos K, Figueroa CM, Griebenow K. Redox-sensitive cross-linking enhances albumin nanoparticle function as delivery system for photodynamic cancer therapy. J Nanomed Nanotechnol 2016; 6: 294.
28. Demirkurt B, Cakan-Akdogan G, Akdogan Y. Preparation of albumin nanoparticles in water-in-ionic liquid microemulsions. J Mol Liq 2019 ; 295: 111713.
29. Lee SH, Heng D, Ng WK, Chan H-K, Tan RBH. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. Int J Pharm 2011; 403: 192-200.
30. Jahanshahi M, Najafpour G, Rahimnejad M. Applying the Taguchi method for optimized fabrication of bovine serum albumin (BSA) nanoparticles as drug delivery vehicles. African J Biotechnol 2008; 7: 362-367.
31. Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem 2009; 17: 2950-2962.
32. Kulkarni SA, Feng S-S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res 2013; 30: 2512-2522.
33. Pakdel M, Moosavi-Nejad Z, Kermanshahi RK, Hosano H. Self-assembled uniform keratin nanoparticles as building blocks for nanofibrils and nanolayers derived from industrial feather waste. J Clean Prod 2022; 335: 130331.
34. Guo C, Guo X, Chu W, Jiang N, Li H. Spectroscopic study of conformation changes of bovine serum albumin in aqueous environment. Chin Chem Lett 2019; 30: 1302-1306.
35. Habibullah G, Viktorova J, Ruml T. Current strategies for noble metal nanoparticle synthesis. Nanoscale Res Lett 2021; 16: 47.
36. Ghadami SA, Ahmadi Z, Moosavi-Nejad Z. The albumin-based nanoparticle formation in relation to protein aggregation. Spectrochim Acta A Mol Biomol Spectrosc 2021; 252: 119489.
37. Wyatt PJ. Differencial light scattering and the measurement of molecules and nanoparticles: a review. Anal Chim Acta X 2021; 7-8: 100070.
38. Li A, Schertzer JW, Yong X. Molecular dynamics modeling of Pseudomonas aeruginosa outer membranes. Phys Chem Chem Phys 2018; 20: 23635-23648.
39. Jürgens G, Müller M, Garidel P, Koch MHJ, Nakakubo H, Blume A, et al. Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A. J Endotoxin Res 2002; 8: 115-126.
40. Arzumanyan VG, Ozhovan IM, Svitich OA. Antimicrobial effect of albumin on bacteria and yeast cells. Bull Exp Biol Med 2019; 167: 763-766.
| Files | ||
| Issue | Vol 15 No 5 (2023) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijm.v15i5.13875 | |
| Keywords | ||
| Bovine serum albumin; Nanoparticles; Antibacterial activity; Antibiotic resistance; Green synthesis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
